UPDATE 1-AbbVie sales blow past forecasts, fueled by Humira
October 31, 2014 at 08:45 AM EDT
Oct 31 (Reuters) - AbbVie, which this month walked away from a $55 billion deal to buy Dublin drugmaker Shire , on Friday reported quarterly revenue and earnings well above Wall Street expectations, fueled by soaring sales of its Humira arthritis drug.
